Efficacy and safety of inhaled formoterol 4.5 and 9 μg twice daily in Japanese and European COPD patients: Phase III study results

BACKGROUND: This study evaluated the efficacy and safety of the long-acting β(2)-agonist formoterol in patients with moderate-to-severe COPD. METHODS: This double-blind, placebo-controlled, parallel-group, multinational phase III study randomized patients ≥ 40 years of age with moderate-to-severe CO...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Hoofdauteurs: Bogdan, Miron A, Aizawa, Hisamichi, Fukuchi, Yoshinosuke, Mishima, Michiaki, Nishimura, Masaharu, Ichinose, Masakazu
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: BioMed Central 2011
Onderwerpen:
Research Article
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC3233513/
https://ncbi.nlm.nih.gov/pubmed/22085439
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2466-11-51
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items